Dispenser for dispensing a fluid into a nasal cavity
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Claims
The ornamental design for dispenser for dispensing a fluid into a nasal cavity, as shown and described.
D230568 | March 1974 | Byrne |
D372768 | August 13, 1996 | Miller et al. |
D417731 | December 14, 1999 | Butler et al. |
D444227 | June 26, 2001 | Hennemann et al. |
D447953 | September 18, 2001 | Brynestad et al. |
D465152 | November 5, 2002 | Kaufman |
D468423 | January 7, 2003 | Renfrew |
D482442 | November 18, 2003 | Pasternak |
D493883 | August 3, 2004 | Harvey et al. |
D496456 | September 21, 2004 | Harvey et al. |
D501552 | February 1, 2005 | Harvey et al. |
D510135 | September 27, 2005 | Mariotti |
D518569 | April 4, 2006 | Nishibayashi et al. |
Type: Grant
Filed: Nov 6, 2006
Date of Patent: Jul 10, 2007
Assignee: Glaxo Group Limited (Greenford)
Inventors: Matthew Spencer Collins (Henlow), Hugh Alexander Connell (Evesham), Michael Birsha Davies (Ware), Andrew Robert Gibbs (Leamington Spa), Paul Kenneth Rand (Ware), Robert William Tansley (Bidford on Avon)
Primary Examiner: Louis Zarfas
Assistant Examiner: David Muller
Attorney: James P. Riek
Application Number: 29/250,178